5-hydroxytryptophan has been researched along with Myoclonic Jerk in 120 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 14-year-old Saudi boy with cherry red spot-myoclonus syndrome and documented neuraminidase deficiency responded well to titrated doses of 5-hydroxytryptophan as an add-on treatment." | 7.67 | Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan. ( Daif, AK; Gascon, G; Ozand, P; Wallenberg, B, 1988) |
| "In male Swiss mice, muscimol produced myoclonic jerks." | 7.66 | Serotonergic drugs, benzodiazepines and baclofen block muscimol-induced myoclonic jerks in a strain of mice. ( Menon, MK; Vivonia, CA, 1981) |
| " L-5-hydroxytryptophan plus carbidopa was administered to eight patients with this disorder or other syndromes in which myoclonus is prominent." | 7.65 | L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent. ( Growdon, JH; Shahani, BT; Young, RR, 1976) |
| " Coadministration of harmaline (but not harmine) and 5-hydroxytryptophan (tryptamine or m-chlorophenyl-piperazine) induced a lethal convulsive myoclonic syndrome which could not be evoked by either drug separately." | 3.67 | Harmala alkaloids and related beta-carbolines: a myoclonic model and antimyoclonic drugs. ( Pranzatelli, MR; Snodgrass, SR, 1987) |
| "This study evaluated the behavioral elements of three 5-HT-related syndromes (intraperitoneal 5-hydroxytryptophan after intracisternal 5,7-dihydroxytryptamine (DHT), p-chloroamphetamine (PCA), fenfluramine (FF), or combinations of drugs) scored from video-tapes and their relationship to locomotor activity (LMA) photocell recording, regional monoamine concentration and S-1 receptor binding." | 3.67 | Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations. ( Pranzatelli, MR; Snodgrass, SR, 1986) |
| "A 14-year-old Saudi boy with cherry red spot-myoclonus syndrome and documented neuraminidase deficiency responded well to titrated doses of 5-hydroxytryptophan as an add-on treatment." | 3.67 | Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan. ( Daif, AK; Gascon, G; Ozand, P; Wallenberg, B, 1988) |
| "In male Swiss mice, muscimol produced myoclonic jerks." | 3.66 | Serotonergic drugs, benzodiazepines and baclofen block muscimol-induced myoclonic jerks in a strain of mice. ( Menon, MK; Vivonia, CA, 1981) |
| "A myoclonic syndrome consisting of tremor, myoclonus, and seizures was produced following the systemic administration of 5-hydroxytryptophan to adult rats previously given intracisternal injections of 5,7-dihydroxytryptamine and systemic desmethylimipramine, but not in their controls." | 3.65 | Myoclonus after 5-hydroxytryptophan in rats with lesions of indoleamine neurons in the central nervous system. ( Baldessarini, RJ; Cancian, D; Growdon, JH; Stewart, RM, 1976) |
| "Three patients with postanoxic intention myoclonus, two patients with intention tremor, and one patient with cerebral palsy were administered L-5-hydroxytryptophan (L-5HTP), the precursor of serotonin, in combination with MK 486, a peripheral amino acid decarboxylase inhibitor." | 3.65 | Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. ( Sethy, VH; Van Woert, MH, 1975) |
| " L-5-hydroxytryptophan plus carbidopa was administered to eight patients with this disorder or other syndromes in which myoclonus is prominent." | 3.65 | L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent. ( Growdon, JH; Shahani, BT; Young, RR, 1976) |
| "In 6 patients with intention myoclonus, the cerebrospinal fluid concentration of 5-hydroxyindoleacetic acid, a metabolite of serotonin was found to be significantly decreased." | 2.64 | Serotonin and myoclonus. ( Bowers, MB; Jutkowitz, R; Rosenbaum, D; Van Woert, MH, 1976) |
| "So-called symptomatic myoclonus is the type that occurs secondary to an identifiable disorder; it is usually accompanied by other neurological signs and is the most frequent kind." | 2.45 | [Myoclonic spasms: their clinical and neurophysiological characteristics, aetiology and treatment]. ( Erro, ME; Navarro, MC, 2009) |
| "Epileptic myoclonus is that which forms part of an epileptic syndrome with a genetic or idiopathic cause, or that is due to static encephalopathy." | 2.45 | [Myoclonic spasms: their clinical and neurophysiological characteristics, aetiology and treatment]. ( Erro, ME; Navarro, MC, 2009) |
| "The literature on myoclonus and serotonin neuropharmacology reveals evidence for serotonergic abnormalities in some human myoclonic disorders, new serotonin receptor subtypes and data on their molecular structure and function, more selective drugs, and experimental evidence linking certain serotonin receptor subtypes with myoclonus." | 2.39 | Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists. ( Pranzatelli, MR, 1994) |
| "Clonazepam is a potent anticonvulsant 1,4-benzodiazepine that controls some types of myoclonus." | 2.37 | Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT. ( Jenner, P; Marsden, CD; Pratt, JA, 1986) |
| "MDL100." | 1.30 | Head and whole-body jerking in guinea pigs are differentially modulated by 5-HT1A, 5-HT1B/1D and 5-HT2A receptor antagonists. ( Nielsen, CK, 1998) |
| "Myoclonus was induced by the 5-HT precursor L-5-hydroxytryptophan (L-5-HTP) and the non-selective 5-HT1A/1B/5-HT2 receptor agonist 5-methoxy-N,N-dimethyl-tryptamine (5-MeODMT)." | 1.30 | Head and whole-body jerking in guinea pigs are differentially modulated by 5-HT1A, 5-HT1B/1D and 5-HT2A receptor antagonists. ( Nielsen, CK, 1998) |
| "We studied 6 patients with myoclonus elicited by flash stimulation (1-15 Hz)." | 1.29 | The pathophysiology and pharmacology of photic cortical reflex myoclonus. ( Artieda, J; Obeso, JA, 1993) |
| "The data suggest that this rat cardiac arrest model may be a valuable tool for investigating the pathophysiologic mechanisms of posthypoxic myoclonus and for developing new therapeutic strategies for treating the disorder." | 1.29 | Novel rat cardiac arrest model of posthypoxic myoclonus. ( Hussong, MJ; Matsumoto, RR; Schwartz, PH; Truong, DD; Wasterlain, CG, 1994) |
| "The auditory-induced myoclonus continues to worsen, reaches a peak about 2 weeks after the arrest, then declines over time to subnormal levels." | 1.29 | Novel rat cardiac arrest model of posthypoxic myoclonus. ( Hussong, MJ; Matsumoto, RR; Schwartz, PH; Truong, DD; Wasterlain, CG, 1994) |
| "Body weight was reduced both in rats with early and late 5,7-DHT lesions, but reduction persisted in rats with early lesions." | 1.28 | Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan. ( Dollison, AM; Hlibczuk, V; Pranzatelli, MR, 1989) |
| "Pretreatment with 5-hydroxytryptophan (5-HTP), a precursor of 5-HT, antagonised while pretreatment with p-chlorophenylalanine (PCPA), a 5-HT depletor, potentiated the myoclonus induced by picrotoxin, a GABA antagonist." | 1.28 | A functional interaction between GABA and 5-HT in inhibiting picrotoxin-induced myoclonus in rats. ( Krishnamoorthy, MS; Paul, V, 1990) |
| "Pretreatment with aminooxyacetic acid (AOAA), a GABA transaminase inhibitor, antagonised picrotoxin-induced myoclonus." | 1.28 | A functional interaction between GABA and 5-HT in inhibiting picrotoxin-induced myoclonus in rats. ( Krishnamoorthy, MS; Paul, V, 1990) |
| "Ro 15-1788 completely blocked type B myoclonus without decreasing the level of vigilance in the two types of baboons, and reversed the antiepileptic action of the BZs in the photosensitive ones, permitting the reappearance of myoclonus following EEG paroxysmal discharges (type A)." | 1.27 | Differential effects of the benzodiazepine antagonist Ro 15-1788 on two types of myoclonus in baboon Papio papio. ( Bryere, P; Kaijima, M; Naquet, R; Valin, A, 1983) |
| "From a family with essential familial myoclonus, 150 members in eight generations were studied." | 1.27 | Essential familial myoclonus. ( Muhr, H; Przuntek, H, 1983) |
| "A patient with long-standing intention myoclonus was treated with oral clonazepam, which resulted in clinical and electrophysiologic improvement as manifested by dramatic reduction in intention myoclonus and diminished amplitude of somatosensory evoked potentials after treatment." | 1.27 | Posttraumatic intention myoclonus. ( Bjork, RJ; Snyder, BD; Starosta-Rubinstein, S; Tulloch, JW, 1983) |
| "This treatment produced also myoclonus and increased the time spent resting during trials." | 1.27 | Effects of the chronic ingestion of therapeutic doses of chlorimipramine on the behavioral action of agonists and antagonists of serotonin in male rats. ( Broitman, ST; Fóscolo, MR; Rodríguez Echandía, EL, 1983) |
| "L-5-hydroxytryptophan (L-5-HTP)-induced myoclonus was used as a behavioral index of central serotonergic activity." | 1.27 | Estradiol and progesterone influence a serotonin mediated behavioral syndrome (myoclonus) in female guinea pigs: comparison with steroid effects on reproductive behavior. ( Feder, HH; O'Connor, LH, 1984) |
| "Indoleamine-induced myoclonus in guinea pigs is a specific model of brainstem 5-HT function that can be used to characterize the indoleamine systems initiating myoclonus." | 1.27 | 5-HT-mediated myoclonus in the guinea pig as a model of brainstem 5-HT and tryptamine receptor action. ( Jenner, P; Luscombe, G; Marsden, CD, 1986) |
| "p,p'-DDT-induced myoclonus in mice has been proposed as a model of stimulus-sensitive action myoclonus responsive to L-5-HTP and clonazepam treatment." | 1.27 | p,p'-DDT-induced myoclonus in the rat and its application as an animal model of 5-HT-sensitive action myoclonus. ( Jenner, P; Marsden, CD; Pratt, JA; Rothwell, J, 1986) |
| "Posthypoxic action myoclonus is usually associated with impaired serotonin (5-HT) neurotransmission but in some patients 5-HT precursors aggravate and 5-HT blockers improve action myoclonus." | 1.27 | Clinical, biochemical, and pharmacological observation in a patient with postasphyxic myoclonus: association to serotonin hyperactivity. ( De Yebenes, JG; Giménez-Roldán, S; Mateo, D; Muradas, V, 1988) |
| "Some types of intention myoclonus respond to serotonin precursor therapy (e." | 1.27 | Fluoxetine in the treatment of intention myoclonus. ( Chung, E; Magnussen, I; Rosenbaum, D; Van Woert, MH, 1983) |
| "Abnormal movements (myoclonus, lateral head weaving) of the myoclonic syndromes were better antagonized than postural abnormalities (hindlimb abduction, hunching of back)." | 1.27 | Antimyoclonic properties of S2 serotonin receptor antagonists in the rat. ( Pranzatelli, MR; Snodgrass, SR, 1986) |
| "This chapter concerns palatal myoclonus." | 1.27 | Palatal myoclonus. ( Lapresle, J, 1986) |
| "Multiple forms of myoclonus (appendicular and truncal) and convulsions were dose-dependent drug effects." | 1.27 | Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations. ( Pranzatelli, MR; Snodgrass, SR, 1986) |
| "The neurochemical basis of myoclonus responding to 5HT precursors and clonazepam is discussed." | 1.26 | Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. ( Chadwick, D; Hallett, M; Harris, R; Jenner, P; Marsden, CD; Reynolds, EH, 1977) |
| "Such myoclonus may be induced also by the administration of L-tryptophan plus a monamine oxidase inhibitor (MAOI), or by agents acting as serotonin (5-HT) receptor agonists." | 1.26 | 5-hydroxytryptophan-induced myoclonus in guinea pigs. A physiological and pharmacological investigations. ( Chadwick, D; Hallett, M; Jenner, P; Marsden, CD, 1978) |
| "Post-hypoxic intention myoclonus successfully treated by long-term administration of the combination of 5-hydroxytryptophan and carbidopa is described." | 1.26 | Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor. ( de Fine Olivarius, B; Dupont, E; Engbaek, F; Magnussen, I, 1978) |
| "It is suggested that myoclonus induced by tryptamine in guinea pigs pretreated with pargyline involves activation of post-synaptic indoleamine receptors by tryptamine by a mechanism which requires intact presynaptic function of 5HT." | 1.26 | Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systems. ( Jenner, P; Luscombe, G; Marsden, CD, 1982) |
| "In two patients with postanoxic action myoclonus, L-tryptophan or a monoamine oxidase inhibitor induced a moderate improvement, but L-5-hydroxytryptophan had greater therapeutic effect." | 1.26 | Beneficial effects of serotonin precursors in postanoxic action myoclonus. ( De Léan, J; Hornykiewicz, O; Richardson, JC, 1976) |
| "A patient with post-hypoxic myoclonus, sensitive to therapy with 5-hydroxytryptophan and clonazepam, was subjected to detailed electrophysiological investigation." | 1.26 | Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus. ( Adam, J; Chadwick, D; Hallett, M; Marsden, CD, 1977) |
| "Postanoxic myoclonus was first accepted as being related to a dysfunction of the ventrolateral thalamic nucleus." | 1.26 | Postanoxic myoclonus. Treatment of a case with 5-hydroxytryptophane and a decarboxylase inhibitor. ( Beretta, E; de Crousaz, G; Regli, F; Steck, AJ, 1981) |
| "The bioavailability of orally administered L-5-hydroxytryptophan in steady state was investigated at four increasing multiple dose levels in five patients suffering from various myoclonic disorders." | 1.26 | Bioavailability and related pharmacokinetics in man of orally administered L-5-hydroxytryptophan in steady state. ( Magnussen, I; Nielsen-Kudsk, F, 1980) |
| " The finding of a direct proportionality between the size of the oral dose level of L-5-hydroxytryptophan and the corresponding areas under the plasma concentration curves within a dosage interval at steady state strongly indicates dose independent, linear pharmacokinetics of the compound." | 1.26 | Bioavailability and related pharmacokinetics in man of orally administered L-5-hydroxytryptophan in steady state. ( Magnussen, I; Nielsen-Kudsk, F, 1980) |
| "p,p'-DDT-treated rats had increased concentrations of 5-hydroxyindoleacetic acid (5-HIAA) in seven regional areas, but serotonin was increased only in the midbrain and cerebellum." | 1.26 | p,p'-DDT-induced neurotoxic syndrome: experimental myoclonus. ( Hwang, EC; Van Woert, MH, 1978) |
| "Myoclonus was induced in guinea pigs in a dose-dependent manner by intraperitoneal injection of L-5-hydroxytryptophan (L-5-HTP)." | 1.26 | Functional anatomy of L-5-hydroxytryptophan-induced myoclonus in the guinea pig. ( Thal, LJ; Wolfson, LI, 1981) |
| " At a dosage of 400 mg per kilogram, all animals developed myoclonus." | 1.26 | Functional anatomy of L-5-hydroxytryptophan-induced myoclonus in the guinea pig. ( Thal, LJ; Wolfson, LI, 1981) |
| "We postulate that p,p'-DDT-induced myoclonus may be causally related to blockage of serotonin receptors or inhibition of serotonin release into the synapse, resulting in functional deficiency of this neurotransmiter at the receptor site." | 1.26 | p,p'-DDT-induced neurotoxic syndrome: experimental myoclonus. ( Hwang, EC; Van Woert, MH, 1978) |
| "In 18 patients with intention myoclonus due to anoxia or other brain damage, 11 derived more than 50% overall improvement during treatment with L-5HTP and carbidopa." | 1.26 | Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. ( Bowers, MB; Howieson, J; Rosenbaum, D; Van Woert, MH, 1977) |
| "Six patients with myoclonus of varying cause were treated with L-5-hydroxytryptophan (L-5-HTP) and carbidopa." | 1.26 | Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations. ( Katzman, R; Sharpless, NS; Thal, LJ; Wolfson, L, 1980) |
| "Progress in the treatment of action myoclonus is especially noteworthy and has led to the implication of serotonin deficit in the pathophysiology of this syndrome." | 1.26 | New approaches in the management of hyperkinetic movement disorders. ( Fahn, S, 1977) |
| "Three patients with postanoxic intention myoclonus, two patients with intention tremor, and one patient with cerebral palsy were administered L-5-hydroxytryptophan (L-5HTP), the precursor of serotonin, in combination with MK 486, a peripheral amino acid decarboxylase inhibitor." | 1.25 | Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. ( Sethy, VH; Van Woert, MH, 1975) |
| "The response of myoclonus to oral and intravenous L-5-hydroxytryptophan (5-H." | 1.25 | Manipulation of brain serotonin in the treatment of myoclonus. ( Chadwick, D; Harris, R; Jenner, P; Marsden, CD; Reynolds, EH, 1975) |
| "Levodopa-induced myoclonus may be related to intermittent increases of activity of serotonin in the brain and results from levodopa-induced dysregulation of serotonin activity." | 1.25 | Levodopa-induced myoclonus. ( Bergen, D; Goetz, C; Klawans, HL, 1975) |
| " Although directly related to daily dosage of levodopa, the myoclonus was specifically blocked by the serotonin antagonist, methysergide." | 1.25 | Levodopa-induced myoclonus. ( Bergen, D; Goetz, C; Klawans, HL, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 108 (90.00) | 18.7374 |
| 1990's | 10 (8.33) | 18.2507 |
| 2000's | 2 (1.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erro, ME | 1 |
| Navarro, MC | 1 |
| Menon, MK | 1 |
| Vivonia, CA | 1 |
| Luscombe, G | 3 |
| Jenner, P | 10 |
| Marsden, CD | 14 |
| Valin, A | 1 |
| Kaijima, M | 1 |
| Bryere, P | 1 |
| Naquet, R | 1 |
| Beretta, E | 1 |
| Regli, F | 2 |
| de Crousaz, G | 1 |
| Steck, AJ | 1 |
| Van Woert, MH | 14 |
| Magnussen, I | 8 |
| Lowe, YH | 1 |
| Hwang, EC | 3 |
| Rosenbaum, D | 5 |
| Chung, E | 1 |
| Przuntek, H | 1 |
| Muhr, H | 1 |
| Mondrup, K | 1 |
| Engbaek, F | 2 |
| Lademann, A | 1 |
| Olivarius, BD | 1 |
| Feit, H | 1 |
| Kirkpatrick, J | 1 |
| Pandian, G | 1 |
| Starosta-Rubinstein, S | 1 |
| Bjork, RJ | 1 |
| Snyder, BD | 1 |
| Tulloch, JW | 1 |
| Meyers, AS | 1 |
| Rodríguez Echandía, EL | 1 |
| Broitman, ST | 1 |
| Fóscolo, MR | 1 |
| Sunohara, N | 1 |
| Mukoyama, M | 1 |
| Mano, Y | 1 |
| Satoyoshi, E | 2 |
| O'Connor, LH | 3 |
| Feder, HH | 2 |
| Nielsen-Kudsk, F | 1 |
| Thal, LJ | 3 |
| Sharpless, NS | 1 |
| Wolfson, L | 2 |
| Katzman, R | 2 |
| Wolfson, LI | 2 |
| Avanzini, G | 2 |
| Bossi, L | 1 |
| Caraceni, T | 1 |
| Consolazione, A | 1 |
| Franceschetti, S | 2 |
| Negri, S | 1 |
| Parati, E | 1 |
| Nausieda, PA | 4 |
| Carvey, PM | 4 |
| Weiner, WJ | 5 |
| Lombardi, B | 1 |
| Passerini, A | 1 |
| Braun, A | 1 |
| Sternberg, EM | 1 |
| Young, SN | 1 |
| Baker, H | 1 |
| Gauthier, S | 1 |
| Osterland, CK | 1 |
| Pranzatelli, MR | 10 |
| Matsumoto, RR | 2 |
| Aziz, N | 1 |
| Truong, DD | 2 |
| Artieda, J | 1 |
| Obeso, JA | 1 |
| Schwartz, PH | 1 |
| Hussong, MJ | 1 |
| Wasterlain, CG | 1 |
| Galvan, I | 1 |
| Tailor, PT | 1 |
| Nielsen, CK | 1 |
| Frucht, SJ | 1 |
| Klawans, HL | 10 |
| Trimble, M | 1 |
| Chadwick, D | 8 |
| Reynolds, EH | 4 |
| Harris, R | 2 |
| DeLéan, J | 1 |
| Richardson, JC | 3 |
| Stewart, RM | 4 |
| Campbell, A | 2 |
| Sperk, G | 2 |
| Baldessarini, RJ | 4 |
| Levin, SL | 1 |
| Munsat, TL | 1 |
| Dupont, E | 2 |
| Prange-Hansen, A | 1 |
| de Fine Olivarius, B | 2 |
| Hallett, M | 4 |
| Adam, J | 1 |
| Hallet, M | 1 |
| Goetz, C | 5 |
| Fahn, S | 1 |
| Gerson, SC | 1 |
| Growdon, JH | 4 |
| Volkman, PH | 1 |
| Lorens, SA | 1 |
| Kindel, GH | 1 |
| Ginos, JZ | 1 |
| Carroll, WM | 1 |
| Walsh, PJ | 1 |
| Howieson, J | 1 |
| Bowers, MB | 2 |
| Jutkowitz, R | 1 |
| Sethy, VH | 2 |
| Bergen, D | 1 |
| Lhermitte, F | 2 |
| Degos, CF | 1 |
| Marteau, R | 2 |
| Chazot, G | 1 |
| Guard, O | 1 |
| Setiey, A | 1 |
| Robert, JM | 1 |
| Schott, B | 1 |
| D'Amico, DJ | 1 |
| Patel, BC | 1 |
| Cancian, D | 2 |
| De Léan, J | 2 |
| Hornykiewicz, O | 2 |
| Young, RR | 1 |
| Shahani, BT | 1 |
| Kinoshita, M | 1 |
| Takazawa, Y | 1 |
| Yoda, K | 1 |
| Thal, L | 1 |
| Sharpless, N | 1 |
| Engel, J | 1 |
| Jiménez-Jiménez, FJ | 1 |
| Roldan, A | 1 |
| Zancada, F | 1 |
| Molina-Arjona, JA | 1 |
| Fernandez-Ballesteros, A | 1 |
| Santos, J | 1 |
| Paul, V | 2 |
| Krishnamoorthy, MS | 2 |
| Bhatt, M | 1 |
| Snow, B | 1 |
| Varelas, M | 1 |
| Calne, D | 1 |
| Nakano, K | 1 |
| Hayakawa, T | 1 |
| Shishikura, K | 1 |
| Ohsawa, M | 1 |
| Suzuki, H | 1 |
| Fukuyama, Y | 1 |
| Chung, EY | 2 |
| Rewcastle, NB | 1 |
| Pratt, JA | 2 |
| Rothwell, J | 1 |
| Giménez-Roldán, S | 1 |
| Mateo, D | 1 |
| Muradas, V | 1 |
| De Yebenes, JG | 1 |
| Dollison, AM | 1 |
| Hlibczuk, V | 1 |
| Snodgrass, SR | 6 |
| Uldry, PA | 1 |
| Gobbi, G | 1 |
| Melideo, G | 1 |
| Giovanardi Rossi, P | 1 |
| Chapman, AG | 1 |
| Bo, P | 2 |
| Camana, C | 1 |
| Curti, M | 1 |
| Fussi, F | 1 |
| Giorgetti, A | 1 |
| Savoldi, F | 2 |
| Gascon, G | 1 |
| Wallenberg, B | 1 |
| Daif, AK | 1 |
| Ozand, P | 1 |
| Lapresle, J | 1 |
| Tanner, CM | 1 |
| Goetz, CG | 3 |
| Carvey, P | 1 |
| Paulseth, JE | 1 |
| Brown, LL | 1 |
| Rubin, G | 1 |
| Patrucco, M | 1 |
| Lieberman, JA | 2 |
| Kane, JM | 2 |
| Reife, R | 2 |
| Fischette, CT | 1 |
| Fischer-Perroudon, C | 1 |
| Mouret, J | 1 |
| Jouvet, M | 1 |
| Rohmer, F | 1 |
| Warter, JM | 1 |
| Coquillat, G | 1 |
| Maitrot, D | 1 |
| Kurtz, D | 1 |
| Micheletti, G | 1 |
| Mack, G | 1 |
| Mandel, P | 1 |
| Westheimer, R | 1 |
| Guilleminault, C | 1 |
| Tharp, BR | 1 |
| Cousin, D | 1 |
| Sabouraud, O | 1 |
| Chatel, M | 1 |
| Badiche, A | 1 |
| Chauvel, P | 1 |
| Le Clec'h, G | 1 |
| Clineschmidt, BV | 1 |
| Lotti, VJ | 1 |
| Bieger, D | 1 |
| Larochelle, L | 1 |
| Peterfalvi, M | 1 |
| Gazengel, J | 1 |
| Serdaru, M | 1 |
9 reviews available for 5-hydroxytryptophan and Myoclonic Jerk
| Article | Year |
|---|---|
[Myoclonic spasms: their clinical and neurophysiological characteristics, aetiology and treatment].
Topics: 5-Hydroxytryptophan; Anticonvulsants; Antidepressive Agents, Second-Generation; Diagnosis, Different | 2009 |
Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists.
Topics: 5-Hydroxytryptophan; Brain; Humans; Hydroxyindoleacetic Acid; Myoclonus; Receptors, Serotonin; Serot | 1994 |
Myoclonus.
Topics: 5-Hydroxytryptophan; Humans; Myoclonus; Serotonin | 1975 |
Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT.
Topics: 5-Hydroxytryptophan; Animals; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Brain; Clonazepam | 1986 |
[Indications for L-5-hydroxytryptophan in neurology].
Topics: 5-Hydroxytryptophan; Down Syndrome; Epilepsy; Humans; Migraine Disorders; Myoclonus; Pain; Parkinson | 1987 |
The pharmacology of myoclonus.
Topics: 5-Hydroxytryptophan; Adrenocorticotropic Hormone; Animals; Anticonvulsants; Benzodiazepines; Brain; | 1985 |
Valproate and myoclonus.
Topics: 5-Hydroxytryptophan; Amino Acids; Animals; Aspartic Acid; Clonazepam; DDT; Disease Models, Animal; F | 1986 |
Neuromuscular effects of monoamine oxidase inhibitors.
Topics: 5-Hydroxytryptophan; Adult; Animals; Clomipramine; Clorgyline; Depressive Disorder; Female; Humans; | 1986 |
Hormone effects on serotonin-dependent behaviors.
Topics: 5-Hydroxytryptophan; Androgens; Animals; Behavior, Animal; Estrogens; Female; Guinea Pigs; Male; Myo | 1986 |
4 trials available for 5-hydroxytryptophan and Myoclonic Jerk
| Article | Year |
|---|---|
Myoclonus and L-5-hydroxytryptophan (L-5HTP).
Topics: 5-Hydroxytryptophan; Carbidopa; Clinical Trials as Topic; Drug Industry; Drug Therapy, Combination; | 1983 |
Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Therapy, Com | 1980 |
Serotonin and myoclonus.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Carbidopa; Clinical Trials as Topic; Epilepsy; Female; Homov | 1976 |
[Pharmacological and biochemical approach to a syndrome of action and intention myoclonus in the course of degenerative disease of the nervous system].
Topics: 5-Hydroxytryptophan; Adult; Benzazepines; Cerebellar Ataxia; Clinical Trials as Topic; Diagnosis, Di | 1973 |
107 other studies available for 5-hydroxytryptophan and Myoclonic Jerk
| Article | Year |
|---|---|
Serotonergic drugs, benzodiazepines and baclofen block muscimol-induced myoclonic jerks in a strain of mice.
Topics: 5-Hydroxytryptophan; Animals; Anti-Anxiety Agents; Baclofen; Benzodiazepines; Male; Mice; Muscimol; | 1981 |
Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systems.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Female; Guinea Pigs; Monoamine Oxidase Inhibitors; M | 1982 |
Differential effects of the benzodiazepine antagonist Ro 15-1788 on two types of myoclonus in baboon Papio papio.
Topics: 5-Hydroxytryptophan; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepinones; Flumazenil; g | 1983 |
Postanoxic myoclonus. Treatment of a case with 5-hydroxytryptophane and a decarboxylase inhibitor.
Topics: 5-Hydroxytryptophan; Benserazide; Humans; Hydrazines; Hydroxyindoleacetic Acid; Hypoxia; Male; Middl | 1981 |
Study of serotonin in neuropsychiatric disorders.
Topics: 5-Hydroxytryptophan; Carbidopa; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Kinetic | 1982 |
Fluoxetine in the treatment of intention myoclonus.
Topics: 5-Hydroxytryptophan; Adult; Blood Platelets; Carbidopa; Female; Fluoxetine; Humans; Hydroxyindoleace | 1983 |
Alterations in brain 5HT and tryptamine content during indoleamine-induced myoclonus in guinea pigs.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Brain; Carbidopa; Drug Interactions; Female; Guinea | 1983 |
Essential familial myoclonus.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Child; Female; Germany, West; Humans; Male; Middle Age | 1983 |
Treatment of myoclonic syndromes with paroxetine alone or combined with 5-HTP.
Topics: 5-Hydroxytryptophan; Adult; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myoclonus; | 1982 |
Myoclonus, ataxia, and hypoventilation: response to L-5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Adult; Ataxia; Female; Humans; Hypoventilation; Mitochondria, Muscle; Myoclonus | 1983 |
Posttraumatic intention myoclonus.
Topics: 5-Hydroxytryptophan; Benzodiazepinones; Brain Damage, Chronic; Clonazepam; Evoked Potentials, Somato | 1983 |
Orphan drugs and orphan diseases: the consumer's viewpoint.
Topics: 5-Hydroxytryptophan; Drug Industry; Humans; Legislation, Drug; Myoclonus; Tourette Syndrome; United | 1983 |
L-5 HTP available under treatment IND.
Topics: 5-Hydroxytryptophan; Humans; Myoclonus; Professional Staff Committees; United States; United States | 1983 |
Effects of the chronic ingestion of therapeutic doses of chlorimipramine on the behavioral action of agonists and antagonists of serotonin in male rats.
Topics: 5-Hydroxytryptophan; Animals; Clomipramine; Exploratory Behavior; Fluoxetine; Male; Methysergide; Mo | 1983 |
Action-induced rhythmic dystonia: an autopsy case.
Topics: 5-Hydroxytryptophan; Cerebral Infarction; Clonazepam; Dystonia; Electroencephalography; Electromyogr | 1984 |
Estradiol and progesterone influence a serotonin mediated behavioral syndrome (myoclonus) in female guinea pigs: comparison with steroid effects on reproductive behavior.
Topics: 5-Hydroxytryptophan; Animals; Drug Interactions; Estradiol; Female; Guinea Pigs; Models, Neurologica | 1984 |
From the NIH: New treatment for myoclonus patients.
Topics: 5-Hydroxytryptophan; Animals; Carbidopa; Depression, Chemical; Humans; Myoclonus; Serotonin | 1980 |
Bioavailability and related pharmacokinetics in man of orally administered L-5-hydroxytryptophan in steady state.
Topics: 5-Hydroxytryptophan; Administration, Oral; Adult; Biological Availability; Carbidopa; Dose-Response | 1980 |
Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Carbidopa; Clonazepam; Diarrhea; Drug Therapy, Combination; | 1980 |
Functional anatomy of L-5-hydroxytryptophan-induced myoclonus in the guinea pig.
Topics: 5-Hydroxytryptophan; Animals; Autoradiography; Brain; Cerebral Cortex; Densitometry; Dose-Response R | 1981 |
Effect of L-5HTP and drugs acting on serotonin metabolism in various myoclonic syndromes.
Topics: 5-Hydroxytryptophan; Brain Chemistry; Clonazepam; Humans; Myoclonic Cerebellar Dyssynergia; Myoclonu | 1980 |
Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration.
Topics: 5-Hydroxytryptophan; Adrenal Cortex Hormones; Animals; Apomorphine; Behavior, Animal; Circadian Rhyt | 1982 |
Segmental action and stimuli-sensitive myoclonus with acute onset. A case report.
Topics: 5-Hydroxytryptophan; Acute Disease; Adult; Angiography; Carbidopa; Carotid Arteries; Cerebrovascular | 1980 |
Long-term suppression of central serotonergic activity by corticosteroids: a possible model of steroid-responsive myoclonic disorders.
Topics: 5-Hydroxytryptophan; Adrenal Cortex Hormones; Animals; Apomorphine; Circadian Rhythm; Guinea Pigs; H | 1982 |
Association between brain indole levels and severity of posthypoxic myoclonus in rats.
Topics: 5-Hydroxytryptophan; Analysis of Variance; Animals; Brain; Hydroxyindoleacetic Acid; Hypoxia, Brain; | 1995 |
The pathophysiology and pharmacology of photic cortical reflex myoclonus.
Topics: 5-Hydroxytryptophan; Aged; Aged, 80 and over; Ataxia; Cerebral Cortex; Dopamine Agents; Electroencep | 1993 |
Novel rat cardiac arrest model of posthypoxic myoclonus.
Topics: 5-Hydroxytryptophan; Acoustic Stimulation; Animals; Anticonvulsants; Clonazepam; Disease Models, Ani | 1994 |
Human brainstem serotonin receptors: characterization and implications for subcortical myoclonus.
Topics: 5-Hydroxytryptophan; Adult; Aged; Binding, Competitive; Brain Stem; Cerebral Cortex; Female; Humans; | 1996 |
Head and whole-body jerking in guinea pigs are differentially modulated by 5-HT1A, 5-HT1B/1D and 5-HT2A receptor antagonists.
Topics: 5-Hydroxytryptophan; Animals; Benzazepines; Guinea Pigs; Head Movements; Male; Methoxydimethyltrypta | 1998 |
The clinical challenge of posthypoxic myoclonus.
Topics: 5-Hydroxytryptophan; Anticonvulsants; Clonazepam; Humans; Hypoxia; Levetiracetam; Myoclonus; Neuropr | 2002 |
DDT-induced myoclonus: serotonin and alpha noradrenergic interaction.
Topics: 5-Hydroxytryptophan; Adrenergic alpha-Antagonists; Animals; Brain Chemistry; DDT; Male; Mice; Myoclo | 1979 |
Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Dopamine Antagonists; Ergolines; Guinea Pigs; Haloperidol | 1979 |
Letter: L 5-Hydroxytryptophan and mood.
Topics: 5-Hydroxytryptophan; Affective Symptoms; Aggression; Brain Neoplasms; Depression; Dose-Response Rela | 1975 |
Manipulation of brain serotonin in the treatment of myoclonus.
Topics: 5-Hydroxytryptophan; Administration, Oral; Adult; Aged; Benzodiazepinones; Brain; Carbidopa; Clonaze | 1975 |
Letter: Relief of myoclonus by L-tryptophan.
Topics: 5-Hydroxytryptophan; Administration, Oral; Aged; Female; Humans; Male; Middle Aged; Myoclonus; Trypt | 1975 |
Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.
Topics: 5-Hydroxytryptophan; 5,7-Dihydroxytryptamine; Animals; Brain; Cyproheptadine; Denervation; Desiprami | 1979 |
[Serotoninergic conception of myoclonic syndromes. (Review)].
Topics: 5-Hydroxytryptophan; Animals; Brain; Brain Chemistry; Carbidopa; Dogs; Electroencephalography; Elect | 1979 |
Serotonin and myoclonic seizures.
Topics: 5-Hydroxytryptophan; Humans; Hypoxia, Brain; Myoclonus; Serotonin | 1977 |
Palatal myoclonus treated with 5-hydroxytryptophan and a decarboxylase-inhibitor.
Topics: 5-Hydroxytryptophan; Adult; Carbidopa; Drug Combinations; Humans; Hydrazines; Male; Muscle Contracti | 1977 |
Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus.
Topics: 5-Hydroxytryptophan; Clonazepam; Electroencephalography; Evoked Potentials; Humans; Hypoxia; Male; M | 1977 |
5-Hydroxytryptophan-induced behaviour in guinea-pigs: its relevance to human myoclonus [proceedings].
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Electromyography; Guinea Pigs; Humans; Muscle Contra | 1977 |
Clonazepam and 5-hydroxytryptophan-induced myoclonic stereotypy.
Topics: 5-Hydroxytryptophan; Animals; Behavior; Benzodiazepinones; Brain Chemistry; Clonazepam; Drug Interac | 1977 |
New approaches in the management of hyperkinetic movement disorders.
Topics: 5-Hydroxytryptophan; Carbidopa; Chorea; Dyskinesia, Drug-Induced; Humans; Movement Disorders; Myoclo | 1977 |
5-hydroxytryptophan-induced myoclonus in guinea pigs. A physiological and pharmacological investigations.
Topics: 5-Hydroxytryptophan; Animals; Cyproheptadine; Electromyography; Female; Guinea Pigs; Male; Motor Act | 1978 |
Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor.
Topics: 5-Hydroxytryptophan; Adult; Carbidopa; Drug Evaluation; Drug Therapy, Combination; Humans; Hydrazine | 1978 |
Biochemical, behavioral, and pharmacologic studies of the effects of dihydroxytryptamines in the rodent brain.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Brain; Dihydroxytryptamines; Male; Mice; Myoclonus; | 1978 |
Changes in motor behavior following the administration of serotonin neurotoxins.
Topics: 5-Hydroxytryptophan; 5,7-Dihydroxytryptamine; Animals; Desipramine; Motor Activity; Myoclonus; p-Chl | 1978 |
L-5-Hydroxytryptophan-induced myoclonus in guinea pigs: a model for the study of central serotonin-dopamine interactions.
Topics: 5-Hydroxytryptophan; Animals; Dopamine; Female; Guinea Pigs; Male; Models, Biological; Myoclonus; Re | 1978 |
p,p'-DDT-induced neurotoxic syndrome: experimental myoclonus.
Topics: 5-Hydroxytryptophan; Animals; Brain Chemistry; Clomipramine; DDT; Hydroxyindoleacetic Acid; Isomeris | 1978 |
L-5-hydroxytryptophan therapy in myoclonus.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Carbidopa; Clomipramine; Double-Blind Method; Drug Eva | 1979 |
L-5-hydroxytryptophan therapy in myoclonus: discussion.
Topics: 5-Hydroxytryptophan; Drug Evaluation; Humans; Myoclonus | 1979 |
Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam.
Topics: 5-Hydroxytryptophan; Adult; Benzodiazepinones; Clonazepam; Drug Therapy, Combination; Female; Humans | 1978 |
Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Brain; Carbidopa; Drug Therapy, Combination; Epilepsie | 1977 |
Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Benzodiazepinones; Carbidopa; Child, Preschool; Clonaz | 1977 |
Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Cer | 1975 |
Levodopa-induced myoclonus.
Topics: 5-Hydroxytryptophan; Aged; Amantadine; Amphetamine; Animals; Benztropine; Dopamine Antagonists; Dose | 1975 |
[Letter: Combination of a dopa decarboxylase inhibitor with 5-hydroxytryptophan therapy].
Topics: 5-Hydroxytryptophan; Adult; Aromatic Amino Acid Decarboxylase Inhibitors; Dopa Decarboxylase; Drug S | 1975 |
[Ramsay-Hunt syndrome and aniridia in 2 monozygotic twins].
Topics: 5-Hydroxytryptophan; Adolescent; Benzodiazepinones; Blood Group Antigens; Cerebellar Ataxia; Disease | 1975 |
Behavioral supersensitivity to 5-hydroxytryptophan induced by chronic methysergide pretreatment.
Topics: 5-Hydroxytryptophan; Animals; Behavior; Brain Chemistry; Drug Synergism; Guinea Pigs; Humans; Male; | 1975 |
Myoclonus after 5-hydroxytryptophan in rats with lesions of indoleamine neurons in the central nervous system.
Topics: 5-Hydroxytryptophan; Animals; Benserazide; Brain; Dose-Response Relationship, Drug; Drug Interaction | 1976 |
Beneficial effects of serotonin precursors in postanoxic action myoclonus.
Topics: 5-Hydroxytryptophan; Aged; Carbidopa; Female; Humans; Hydroxyindoleacetic Acid; Hypoxia; Levodopa; M | 1976 |
5-hydroxytryptophan-induced myoclonus: increased sensitivity to serotonin after intracranial 5,7-dihydroxytryptamine in the adult rat.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Brain; Desipramine; Injections; Male; Myoclonus; Rat | 1976 |
L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Carbidopa; Child, Preschool; Drug Evaluation; Female; Humans | 1976 |
[Case of intention myoclonus (Lance-Adams syndrome) and a dramatic effect of L-5-hydroxytryptophan].
Topics: 5-Hydroxytryptophan; Humans; Male; Middle Aged; Myoclonus | 1976 |
Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa.
Topics: 5-Hydroxytryptophan; Adult; Carbidopa; Drug Evaluation; Homovanillic Acid; Humans; Hydrazines; Hydro | 1976 |
Spinal myoclonus: successful treatment with the combination of sodium valproate and L-5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Adult; Drug Therapy, Combination; Humans; Male; Myoclonus; Spinal Cord Diseases | 1991 |
A functional interaction between GABA and 5-HT in inhibiting picrotoxin-induced myoclonus in rats.
Topics: 5-Hydroxytryptophan; Aminooxyacetic Acid; Animals; Fenclonine; gamma-Aminobutyric Acid; Male; Myoclo | 1990 |
Palatal myoclonus: treatment with 5-hydroxytryptophan and carbidopa.
Topics: 5-Hydroxytryptophan; Adult; Carbidopa; Drug Therapy, Combination; Humans; Male; Myoclonus; Palatal M | 1990 |
Improvement of action myoclonus by an administration of 5-hydroxytryptophan and carbidopa in a child with muscular subsarcolemmal hyperactivity.
Topics: 5-Hydroxytryptophan; Carbidopa; Child, Preschool; Humans; Male; Muscles; Muscular Diseases; Myoclonu | 1990 |
Biochemistry and therapeutics of posthypoxic myoclonus.
Topics: 5-Hydroxytryptophan; Adrenocorticotropic Hormone; Aspartic Acid; Benzodiazepines; Carbidopa; Electro | 1986 |
Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder.
Topics: 5-Hydroxytryptophan; Benzodiazepines; Clonazepam; Female; Fenclonine; Humans; Hydroxyindoleacetic Ac | 1986 |
Pathological findings in a case of hypoxic myoclonus treated with 5-hydroxytryptophan and a decarboxylase inhibitor.
Topics: 5-Hydroxytryptophan; Aged; Brain; Carbidopa; Diazepam; Electroencephalography; Female; Fenclonine; H | 1986 |
5-HT-mediated myoclonus in the guinea pig as a model of brainstem 5-HT and tryptamine receptor action.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Brain; Carbidopa; Disease Models, Animal; Guinea Pig | 1986 |
p,p'-DDT-induced myoclonus in the rat and its application as an animal model of 5-HT-sensitive action myoclonus.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Brain; Clonazepam; DDT; Disease Models, Animal; Elec | 1986 |
Possible mechanisms of action of valproic acid in myoclonus.
Topics: 4-Aminobutyrate Transaminase; 5-Hydroxytryptophan; Animals; Brain; gamma-Aminobutyric Acid; Glycine; | 1986 |
Clinical, biochemical, and pharmacological observation in a patient with postasphyxic myoclonus: association to serotonin hyperactivity.
Topics: 5-Hydroxytryptophan; Aged; Humans; Hydroxyindoleacetic Acid; Hypoxia; Male; Methysergide; Myoclonus; | 1988 |
The proposed role of neurotransmitter receptors in the pathophysiology of human myoclonic disorders.
Topics: 5-Hydroxytryptophan; Animals; Biomechanical Phenomena; Humans; Myoclonus; Neurotransmitter Agents; R | 1989 |
Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; 5,7-Dihydroxytryptamine; Age Factors; Animals; Behavior, Animal; Body Weight; B | 1989 |
Antimyoclonic properties of S2 serotonin receptor antagonists in the rat.
Topics: 5-Hydroxytryptophan; Animals; Brain Chemistry; Butyrophenones; Cinanserin; Ketanserin; Male; Myoclon | 1986 |
Evidence for synergism between the antimyoclonic actions of 5-hydroxytryptophan and clonazepam in rats.
Topics: 5-Hydroxytryptophan; Allylglycine; Animals; Cerebral Cortex; Clonazepam; Dose-Response Relationship, | 1988 |
Estradiol and progesterone influence L-5-hydroxytryptophan-induced myoclonus in male guinea pigs: sex differences in serotonin-steroid interactions.
Topics: 5-Hydroxytryptophan; Androgens; Animals; Drug Interactions; Estradiol; Female; Guinea Pigs; Male; My | 1985 |
p,p'-DDT-induced myoclonus in mice: the effect of enhanced 5-HT neurotransmission.
Topics: 5-Hydroxytryptophan; Animals; Carbidopa; DDT; Female; Mice; Mice, Inbred Strains; Myoclonus; Paroxet | 1985 |
The effect of intravenous L-5-HTP in the myoclonic encephalopathy of infants.
Topics: 5-Hydroxytryptophan; Adrenocorticotropic Hormone; Drug Therapy, Combination; Female; Ganglioneuroma; | 1986 |
Experimental study on central effects of carboxyethyl-gamma-aminobutyric acid (CEGABA).
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Brain; Disease Models, Animal; Electroencephalograph | 1988 |
Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Adolescent; Female; Humans; Male; Myoclonus; Neuraminidase; Pedigree; Syndrome | 1988 |
Palatal myoclonus.
Topics: 5-Hydroxytryptophan; Humans; Myoclonus; Palate | 1986 |
Drug-induced myoclonus.
Topics: 5-Hydroxytryptophan; Anesthetics; Animals; Anti-Bacterial Agents; Antidepressive Agents; Bismuth; Ca | 1986 |
L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Bromocriptine; Clonazepam; Disease Models, Animal; Guinea | 1986 |
Serotonin models of myoclonus in the guinea pig and rat.
Topics: 5-Hydroxytryptophan; Animals; Autoradiography; Behavior, Animal; Deoxyglucose; Disease Models, Anima | 1986 |
Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
Topics: 5-Hydroxytryptophan; 5,7-Dihydroxytryptamine; Amphetamines; Animals; Biogenic Amines; Brain; Brain C | 1986 |
Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
Topics: 5-Hydroxytryptophan; 5,7-Dihydroxytryptamine; Amphetamines; Animals; Dihydroxytryptamines; Drug Inte | 1986 |
Neuropharmacological profile of ketanserin.
Topics: 5-Hydroxytryptophan; Animals; Autonomic Nervous System; Behavior, Animal; Electroencephalography; He | 1987 |
Harmala alkaloids and related beta-carbolines: a myoclonic model and antimyoclonic drugs.
Topics: 5-Hydroxytryptophan; Alkaloids; Animals; Carbolines; Male; Motor Activity; Myoclonus; Rats; Rats, In | 1987 |
The guinea pig myoclonic model: behavioral supersensitivity to 5-hydroxytryptophan induced by intracisternal 5,7-dihydroxytryptamine.
Topics: 5-Hydroxytryptophan; 5,7-Dihydroxytryptamine; Animals; Behavior, Animal; Brain; Cisterna Magna; Dihy | 1987 |
Neuromuscular effects of monoamine oxidase inhibitors.
Topics: 5-Hydroxytryptophan; Adult; Animals; Dopamine; Electroencephalography; Female; Humans; Male; Middle | 1985 |
[Case of agrypnia (4 months without sleep) in Morvan's disease. Favorable action of 5-hydroxytryptophan].
Topics: 5-Hydroxytryptophan; Adult; Chorea; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Ele | 1974 |
Letter: Myoclonus, methysergide, and serotonin.
Topics: 5-Hydroxytryptophan; Animals; Dihydroxyphenylalanine; Drug Antagonism; Guinea Pigs; Humans; Methyser | 1974 |
Letter: Treatment of post-anoxic intention myoclonus.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Carbidopa; Drug Evaluation; Drug Synergism; Drug Therapy, Co | 1974 |
Letter: Relief of action myoclonus by 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Animals; Brain Concussion; Female; Guinea Pigs; Humans; Infusions, Parenteral; | 1974 |
5-Hydroxytryptophan-induced myoclonus in guinea pigs and the possible role of serotonin in infantile myoclonus.
Topics: 5-Hydroxytryptophan; Animals; Chlorpromazine; Guinea Pigs; Injections, Subcutaneous; Male; Methyserg | 1973 |
Serotonergic and antiserotonergic influences on amphetamine-induced stereotyped behavior.
Topics: 5-Hydroxytryptophan; Acetylcholine; Animals; Basal Ganglia Diseases; Behavior, Animal; Corpus Striat | 1973 |
HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Chorea; Dopamine; Dystonia Musculorum Deformans; Femal | 1973 |
[Observations on the use of 5 HTP in clinical medicine].
Topics: 5-Hydroxytryptophan; Epilepsy; Humans; Male; Mental Disorders; Movement Disorders; Myoclonus; Thinki | 1972 |
Studies on the interaction of reserpine, d-amphetamine, apomorphine and 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Behavior, Animal; Dextroamphetamine; Dose-Response Relati | 1974 |
Indoleamine antagonists: relative potencies as inhibitors of tryptamine- and 5-hydroxytryptophan-evoked responses.
Topics: 5-Hydroxytryptophan; Anilides; Animals; Cinnamates; Cyproheptadine; Ergolines; Female; Foot; Head; M | 1974 |
A model for the quantitative study of central dopaminergic and serotoninergic activity.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Caudate Nucleus; Chlorpromazine; Dihydroxyphenylalanine; | 1972 |
[Pharmacological analysis of a case of postanoxic intention and action myoclonus].
Topics: 5-Hydroxytryptophan; Alcohols; Anticonvulsants; Benzoates; Carbamazepine; Chlorpromazine; Diazepam; | 1971 |